ID

21101

Descripción

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion; ODM derived from: https://clinicaltrials.gov/show/NCT00566358

Link

https://clinicaltrials.gov/show/NCT00566358

Palabras clave

  1. 10/4/17 10/4/17 -
Subido en

10 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT00566358

Eligibility Diabetes Mellitus, Type 2 NCT00566358

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: 18 to 60 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
bmi between 25 and 29,9 kg/m².
Descripción

BMI

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
weight variance less than 5% in the last 3 months.
Descripción

Weight variance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C1711260
previous diagnosis of diabetes type 2.
Descripción

Diabetes mellitus type 2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
insulin requirement, alone or along with oral agents
Descripción

Insulin requirement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C1514873
capacity to understand the procedures of the study.
Descripción

Cognition

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009240
to agree voluntarily to participate of the study, signing an informed consent.
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
positive anti-gad antibodies
Descripción

Anti-gad antibodies

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1167897
laboratorial signal of probable failure of insulin production, i. e., seric peptide c lesser than 1 ng/ml.
Descripción

Laboratory results: failure of insulin production

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2826772
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C0231174
history of hepatic disease like cirrhosis or chronic active hepatitis.
Descripción

Hepatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
kidney dysfunction (creatinine > 1,4 mg/dl in women and > 1,5 mg/dl in men).
Descripción

Serum creatinine measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
hepatic dysfunction: alt and/or ast 3x above upper normal limit.
Descripción

Liver enzymes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1287351
recent history of neoplasia (< 5 years).
Descripción

History of neoplasia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0260455
use of oral or injectable corticosteroids for more than consecutive 14 days in the last three months.
Descripción

Corticosteroid therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149783

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00566358

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: 18 to 60 years.
boolean
C0001779 (UMLS CUI [1])
BMI
Item
bmi between 25 and 29,9 kg/m².
boolean
C1305855 (UMLS CUI [1])
Weight variance
Item
weight variance less than 5% in the last 3 months.
boolean
C0005910 (UMLS CUI [1,1])
C1711260 (UMLS CUI [1,2])
Diabetes mellitus type 2
Item
previous diagnosis of diabetes type 2.
boolean
C0011860 (UMLS CUI [1])
Insulin requirement
Item
insulin requirement, alone or along with oral agents
boolean
C0021641 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
Cognition
Item
capacity to understand the procedures of the study.
boolean
C0009240 (UMLS CUI [1])
Informed consent
Item
to agree voluntarily to participate of the study, signing an informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Anti-gad antibodies
Item
positive anti-gad antibodies
boolean
C1167897 (UMLS CUI [1])
Laboratory results: failure of insulin production
Item
laboratorial signal of probable failure of insulin production, i. e., seric peptide c lesser than 1 ng/ml.
boolean
C2826772 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0231174 (UMLS CUI [1,3])
Hepatic disease
Item
history of hepatic disease like cirrhosis or chronic active hepatitis.
boolean
C0023895 (UMLS CUI [1])
Serum creatinine measurement
Item
kidney dysfunction (creatinine > 1,4 mg/dl in women and > 1,5 mg/dl in men).
boolean
C0201976 (UMLS CUI [1])
Liver enzymes
Item
hepatic dysfunction: alt and/or ast 3x above upper normal limit.
boolean
C1287351 (UMLS CUI [1])
History of neoplasia
Item
recent history of neoplasia (< 5 years).
boolean
C0260455 (UMLS CUI [1])
Corticosteroid therapy
Item
use of oral or injectable corticosteroids for more than consecutive 14 days in the last three months.
boolean
C0149783 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial